Praveen Tyle
2017
In 2017, Praveen Tyle earned a total compensation of $1.3M as Executive Vice President, Research and Development at Lexicon Pharmaceuticals, a 9% decrease compared to previous year.
Compensation breakdown
| Bonus | $165,645 |
|---|---|
| Option Awards | $490,867 |
| Salary | $454,383 |
| Stock Awards | $172,702 |
| Other | $11,736 |
| Total | $1,295,333 |
Tyle received $490.9K in option awards, accounting for 38% of the total pay in 2017.
Tyle also received $165.6K in bonus, $454.4K in salary, $172.7K in stock awards and $11.7K in other compensation.
Rankings
In 2017, Praveen Tyle's compensation ranked 7,735th out of 14,666 executives tracked by ExecPay. In other words, Tyle earned more than 47.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,735 out of 14,666 | 47th |
Division Manufacturing | 2,896 out of 5,772 | 50th |
Major group Chemicals And Allied Products | 943 out of 2,075 | 55th |
Industry group Drugs | 730 out of 1,731 | 58th |
Industry Pharmaceutical Preparations | 569 out of 1,333 | 57th |
Source: SEC filing on March 16, 2018.
Tyle's colleagues
We found four more compensation records of executives who worked with Praveen Tyle at Lexicon Pharmaceuticals in 2017.
2017
Lonnel Coats
Lexicon Pharmaceuticals
Chief Executive Officer
2017
Jeffrey Wade
Lexicon Pharmaceuticals
Chief Financial Officer
2017
Pablo Lapuerta
Lexicon Pharmaceuticals
Chief Medical Officer
2017
Alexander Santini
Lexicon Pharmaceuticals